Login / Signup

Cutaneous Melanocytic Tumor With CRTC1::TRIM11 Translocation : An Emerging Entity Analyzed in a Series of 41 Cases.

John HannaJennifer S KoSteven D BillingsFelix BoivinOlivia BeaudouxDaniel PissalouxFranck TirodeAlvaro LagaChristopher D M FletcherArnaud de la Fouchardiere
Published in: The American journal of surgical pathology (2022)
Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion (CMTCT) is a recently described dermally based neoplasm with melanocytic differentiation. It can easily be confused with clear cell sarcoma and metastatic melanoma. Our understanding of this lesion, including its potential for aggressive disease, has been limited by the small number of previously reported cases (13) and the limited clinical follow-up data. Here, we report a series of 41 CMTCT confirmed by molecular studies. We find that the lesion shows highly uniform and reproducible morphologic, immunohistochemical, and genetic features across a wide variety of anatomic locations and age groups. Among 22 cases with follow-up, 1 local recurrence and 1 nodal metastasis were identified. Our data support the classification of CMTCT as a unique nosologic entity and emphasize the importance of distinguishing this entity from its histologic mimics, especially clear cell sarcoma and metastatic melanoma, to guide therapy and establish accurate prognostic expectations.
Keyphrases
  • clear cell
  • electronic health record
  • big data
  • machine learning
  • deep learning
  • genome wide
  • low grade
  • stem cells
  • dna methylation
  • copy number
  • data analysis
  • mass spectrometry
  • radiation therapy
  • cell therapy